Retatrutide and Hair Loss - Why It Occurs and How to Fix It
Last reviewed on 8 July 2026. We review our treatment guides every six months to keep them accurate.
Retatrutide is one of the most talked about weight-loss injections despite not being approved for public use anywhere. Eli Lilly's triple hormone agonist, a peptide given by injection, has produced striking results in trials, and that has driven a wave of online interest across forums, social media and private groups. Alongside the enthusiasm, a thread of worry has formed around reports of increased hair shedding, mostly among people who have sourced the medication from unregulated suppliers. This guide sets out what the evidence actually shows.
The honest short answer is more nuanced than either extreme you may read online. Retatrutide's own published trials, the Phase 2 study in the New England Journal of Medicine and the Phase 3 TRIUMPH-1 results released in May 2026, did not list hair loss or alopecia among the reported side effects. The most common problems in those trials were gastrointestinal (nausea, diarrhoea, constipation and vomiting), along with an unusual skin-sensitivity effect. However, hair loss is now a recognised emerging signal across this whole class of weight-loss drugs. More than a thousand cases of hair loss have been reported to the US drug-safety database for GLP-1 medicines as a group, and it is listed as a side effect on the approved label of the related Lilly drug tirzepatide, and has been reported in trials of others in the class. Where it happens, the evidence points to the rapid weight loss itself, not a direct attack on the follicle, as the driver.
For the latest official status of retatrutide, see Eli Lilly's news and press releases, which are updated as the trial programme reports.
One point must be made clearly before anything else. Retatrutide is not licensed. As of mid-2026 it has not been approved by the MHRA in the UK or the FDA in the United States, and it is legally available only to people taking part in Eli Lilly's clinical trials. Any product sold online, through private sellers or via informal networks is therefore unregulated. There is no guarantee of correct dosing, purity or even that the contents match the label. Using unregulated medication introduces risks far beyond anything seen in a controlled trial. Always speak to a doctor before considering any weight-loss medication.
Some people have taken unofficial versions regardless, drawn by the promise of rapid weight loss, and it is largely from this group that reports of shedding have surfaced. To make sense of them, it helps to separate the drug itself from the nutritional and metabolic changes that follow a sharp drop in appetite. That distinction is the same pattern already seen with other appetite-suppressing medicines such as Ozempic and Mounjaro.
What the Trials Actually Reported About Hair Loss
It is worth being precise here, because the online picture is confused. In the Phase 2 trial published in the New England Journal of Medicine in 2023, the most common side effects were gastrointestinal and dose-related, mostly mild to moderate. The trial did report a skin-related effect, described as cutaneous hyperesthesia and skin sensitivity, in about 7% of people on retatrutide compared with 1% on placebo, but it did not report alopecia or hair loss as a distinct side effect. The Phase 3 TRIUMPH-1 results released in May 2026 told a similar story: the common side effects were nausea, diarrhoea, constipation, vomiting, an altered skin sensation called dysesthesia, and urinary and respiratory infections. Hair loss again did not appear on that list.
So, taken on its own, retatrutide's trial record does not flag hair loss. That said, absence from a headline side-effect list is not the same as proof of safety, and it needs to be read against the wider picture for this class of drug. A 2025 scoping review found that alopecia has become an emerging adverse effect associated with GLP-1 receptor agonists as a group, with more than a thousand spontaneous reports logged in the US Food and Drug Administration's safety database. The review concluded that where hair loss occurs, it is most plausibly explained by the rapid weight loss these drugs produce, which can trigger a temporary shedding condition called telogen effluvium, rather than by the medicine damaging the follicle directly. The related Lilly drug tirzepatide lists hair loss as a common side effect on its approved label, and alopecia has also been reported in trials of the newer oral drug orforglipron, which is consistent with a class effect driven by weight loss rather than by one specific molecule.
The practical takeaway is measured. There is no good evidence that retatrutide poisons or destroys hair follicles. If shedding happens, the far more likely mechanism is the nutritional and metabolic stress of losing weight quickly, and that form of hair loss is usually temporary. The rest of this guide explains why, and what helps.
Severe Calorie Reduction and Rapid Weight Loss
Retatrutide has powerful appetite-reducing effects. People who have used unofficial versions often describe real difficulty finishing meals or eating enough. When intake falls too far, the body reacts defensively by cutting energy spending on functions it treats as non-essential. Hair growth is one of the first to be scaled back. Follicles shift into a resting state, then shed some months later.
This delay is what causes confusion. Someone may use the medication for a few weeks, stop, and then feel alarmed when the shedding only begins later. The trigger, though, is usually the nutritional shortfall created by rapid weight loss rather than the chemical itself. A dermatology study of telogen effluvium following weight loss found that shedding tended to begin roughly one to three months after the weight came off, and that it typically appeared once a person had lost around 15% of their body weight or was losing weight faster than about 3.5 kg a month. Notably, that study found women were more vulnerable, developing shedding even when they had lost proportionally less weight than men. The hair is not being attacked. It is being deprioritised while the body protects vital organs.
Protein Shortfall When Appetite Falls Too Far
Hair is built almost entirely from a protein called keratin, which is made from amino acids. When appetite is heavily suppressed, protein intake often drops below what the follicles need to function normally. Someone who already ate irregularly may end up eating only partial meals. Faced with a limited supply, the body directs amino acids to the heart, liver and other critical organs first. Hair sits near the bottom of that priority list.
Meeting even basic protein needs can be hard on a drug that blunts appetite this much. As a general guide, many dietitians suggest around 0.75 to 1 gram of protein per kilogram of body weight a day for an average adult, with somewhat higher needs for people who exercise regularly. Anyone falling well short of that for a sustained period is more likely to notice thinning and shedding. Individual requirements vary, so it is worth discussing your own target with a GP or dietitian, particularly if you are eating very little.
In practice, protecting your hair through a period of weight loss comes down to being deliberate about food quality. Aim for a modest calorie deficit rather than an extreme one, make protein a central part of each meal, and fill out the rest with wholegrains, healthy fats and plenty of fruit and vegetables. A registered dietitian can help you set sensible numbers for your own body and goals.
Low Micronutrients from Restricted Eating
Eating far less overall also lowers intake of iron, zinc, folate, vitamin D and the B vitamins. Each of these plays a part in maintaining a healthy hair cycle. People sourcing retatrutide unofficially often describe simply eating much less of the same food, which compounds any existing gaps. A diet that was already low in nutrient density becomes more restricted still.
Nutrient shortfalls are one of the more common contributors to telogen effluvium. The scalp becomes more sensitive to any added stress, and follicles respond by slipping into their resting phase. The remedy is straightforward in principle: reintroduce nutrient-rich meals, widen the variety of what you eat, and, if a doctor agrees it is appropriate, use a multivitamin as short-term support rather than a substitute for food.
Why the Body Sacrifices Hair Under Metabolic Stress
Growing hair is metabolically expensive. It relies on constant cell division and the production of structural protein. When the body senses it cannot fully support its essential organs, it turns down secondary systems. Hair growth, along with nail growth, slows under that pressure. This is a survival response, not a disease, and the follicles usually stay intact and able to regrow once the stress lifts.
This is why shedding from heavy dieting tends to be temporary. Once consistent nutrition returns, follicles gradually resume activity, though the timeline is slow. In the dermatology study mentioned earlier, people recovered on average within about five months without any specific treatment, with a wide range from a few weeks to well over a year depending on how severe the trigger was.
Why Diet Quality Matters More With Potent Weight-Loss Drugs
Many people drawn to retatrutide are carrying excess weight and come from a background of inconsistent eating. It is common to hear descriptions of skipped meals, convenience foods and long-standing gaps in nutrition well before any medication entered the picture. When a drug then sharply reduces appetite, an already inadequate diet simply shrinks further. That is close to the ideal conditions for deficiency-related shedding.
Supporting the body takes some planning. Protein should feature in every meal. Vegetables and fruit still need to be included even when appetite is low. Smoothies made with yoghurt, berries and a scoop of protein powder can be easier to manage on days when eating feels difficult. A multivitamin can offer temporary cover but does not replace whole food.
Keeping muscle mass through weight loss also helps overall stability. Resistance training combined with adequate protein protects the body's reserves and eases the nutritional strain placed on the hair cycle.
Understanding Telogen Effluvium in the Context of Retatrutide Use
The shedding people describe after using retatrutide typically matches telogen effluvium, a diffuse thinning across the whole scalp rather than a receding or bald patch. It is usually temporary. It does not scar the scalp and it does not destroy follicles. Once dietary intake improves, follicles begin returning to their growth phase. That shift generally takes a couple of months to start, and visible regrowth can take a further three to six months as new hairs lengthen. In more severe cases the recovery window can extend beyond nine months.
The reassuring point is that recovery is the norm. Shedding driven by metabolic stress, protein shortfall or vitamin depletion tends to reverse once balance is restored.
When to Seek Medical Advice, and the Role of Hair Transplants
If shedding becomes distressing, prolonged, or comes with symptoms such as fatigue or weakness, it is worth seeing a GP. Blood tests for thyroid function, ferritin, vitamin D, folate and B12 can help clarify what is going on. These issues frequently overlap with rapid weight loss and are worth assessing properly rather than guessing at.
Some people become concerned enough to consider a hair transplant. For telogen effluvium this is not appropriate, because the follicles are still alive and capable of regrowing on their own. A hair transplant is a treatment for patterned or permanent hair loss, where follicles in the balding area have been lost for good. A GP or a qualified trichologist can explain the distinction and point you toward the right care. A hair transplant is only appropriate once a medical professional has confirmed that permanent, patterned loss, rather than temporary shedding, is what you are dealing with.
Why We Do Not Recommend Unofficial Sources of Retatrutide
Interest in retatrutide keeps growing, but the lack of regulation means any unofficial product is unsafe. The dose cannot be trusted. The contents cannot be verified. The long-term risks are unknown, and side effects cannot be predicted when the identity of what is actually in the vial is uncertain. For those reasons, obtaining retatrutide through unregulated suppliers is strongly discouraged.
If retatrutide is eventually approved, it will come with proper oversight, evidence-based dosing and medical supervision. Until then, the risks of unofficial supply far outweigh any potential benefit. If you are struggling with weight, a GP can talk you through the options that are licensed and available now.
Frequently asked questions
Does retatrutide directly cause hair loss?
Not according to its own trial data. Neither the Phase 2 study nor the Phase 3 TRIUMPH-1 results listed hair loss among the reported side effects. However, hair loss is an emerging signal across GLP-1 weight-loss drugs as a class, and where it occurs it is generally attributed to rapid weight loss triggering temporary shedding, rather than the drug harming the follicle itself.
Is hair loss from weight-loss injections permanent?
Usually not. The pattern seen with rapid weight loss is telogen effluvium, a temporary, non-scarring shedding. In a dermatology study of weight-loss-related shedding, people recovered on average within about five months without specific treatment, once nutrition was restored. Recovery can take longer if the trigger was severe.
Why does the shedding start after I stop the medication?
This is normal for telogen effluvium. Follicles pushed into their resting phase by a stressor do not shed straight away. Studies typically show hair falling out roughly one to three months after the trigger, which is why shedding can begin only after a course of rapid weight loss has ended.
Are women more affected than men?
The evidence suggests women may be more vulnerable to weight-loss-related shedding. One dermatology study found women developed telogen effluvium even when they had lost proportionally less weight than men. This is not fully understood, and it should be discussed with a medical professional rather than assumed for any individual.
Is retatrutide approved in the UK?
No. As of mid-2026, retatrutide has not been approved by the MHRA in the UK or the FDA in the United States. It is an investigational drug still in Phase 3 trials and is legally available only to people taking part in Eli Lilly's clinical studies. Anything sold outside those trials is unregulated.
Can a hair transplant fix shedding caused by weight loss?
No, and it is not needed. A hair transplant treats permanent, patterned hair loss where follicles have been lost. Shedding from rapid weight loss is temporary, and the follicles are still alive and able to regrow once nutrition and weight stabilise. A GP or trichologist can confirm which type of hair loss you have before any surgical option is considered.
Get back to Great Hair
in 3 Easy Steps:
01
Arrange Free Consultation
Speak to one of our specialist consultants for expert advice on our range of different hair loss treatments
02
Book Your Procedure
Place a deposit to reserve a time slot at one of the My Hair UK clinics across the UK
03
Attend Your Surgery
Arrive on the day and our specialist surgical team will look after your every need
